Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLD

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2014 by Seoul National University Boramae Hospital
Sponsor:
Information provided by (Responsible Party):
Won Kim, Seoul National University Boramae Hospital
ClinicalTrials.gov Identifier:
NCT02031913
First received: January 8, 2014
Last updated: July 31, 2014
Last verified: July 2014
  Purpose

Hepatic steatosis and insulin resistance are associated with severity of fibrosis in non-alcoholic fatty liver disease (NAFLD) and chronic hepatitis C. However, clinical significance of steatosis and insulin resistance on fibrosis in chronic hepatitis B (CHB) is not well established. The aim was to investigate the relationship between insulin resistance, hepatic steatosis, and fibrosis in patients with CHB.


Condition
Chronic Hepatitis B
Hepatic Fibrosis
Fatty Liver

Study Type: Observational [Patient Registry]
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 2014 Years
Official Title: Association Between Insulin Resistance and Hepatic Fibrosis in Combined Chronic Hepatitis B and Non-alcoholic Fatty Liver Disease

Resource links provided by NLM:


Further study details as provided by Seoul National University Boramae Hospital:

Primary Outcome Measures:
  • Insulin resistance and fibrosis indices [ Time Frame: one year ] [ Designated as safety issue: No ]
    Measurement for insulin resistance and fibrosis index for hepatic fibrosis assessment


Estimated Enrollment: 500
Study Start Date: January 2013
Estimated Study Completion Date: December 2015
Estimated Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts
HBV without FL
Chronic hepatitis B without steatosis
HBV with FL
Chronic hepatitis B patients with steatosis

Detailed Description:

acoustic radiation force impulse elastography

  Eligibility

Ages Eligible for Study:   20 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Chronic hepatitis B patients who showed evidences of hepatic steatosis on ultrasonography

Criteria

Inclusion Criteria:

  • Chronic hepatitis B patients
  • With evidences of hepatic steatosis on ultrasonography or pathology

Exclusion Criteria:

  • significant alcohol consumption or other known liver diseases
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02031913

Locations
Korea, Republic of
Seoul Metropolitan Government Seoul National University Recruiting
Seoul, Korea, Republic of, 156-707
Contact: Won Kim, M.D, PhD    8228702233    drwon1@snu.ac.kr   
Contact: Saekyung Joo, M.D    821089619285    joo.sammy@gmail.com   
Principal Investigator: Won Kim, M.D, PhD         
Sponsors and Collaborators
Seoul National University Boramae Hospital
Investigators
Principal Investigator: Won Kim, Professor Seoul Metropolitan Government Seoul National University Boramae Medical Center
  More Information

No publications provided

Responsible Party: Won Kim, M.D, PhD, Seoul National University Boramae Hospital
ClinicalTrials.gov Identifier: NCT02031913     History of Changes
Other Study ID Numbers: HBV_FL
Study First Received: January 8, 2014
Last Updated: July 31, 2014
Health Authority: Korea: Ministry for Health, Welfare and Family Affairs

Keywords provided by Seoul National University Boramae Hospital:
Chronic hepatitis B
Hepatic fibrosis
Steatosis

Additional relevant MeSH terms:
Hepatitis
Hepatitis A
Hepatitis, Chronic
Hepatitis B
Hepatitis B, Chronic
Hepatitis, Viral, Human
Insulin Resistance
Fatty Liver
Fibrosis
Liver Cirrhosis
Hyperinsulinism
Glucose Metabolism Disorders
Metabolic Diseases
Liver Diseases
Digestive System Diseases
Pathologic Processes
Virus Diseases
Enterovirus Infections
Picornaviridae Infections
RNA Virus Infections
Hepadnaviridae Infections
DNA Virus Infections

ClinicalTrials.gov processed this record on September 16, 2014